TNFSF10 and atherosclerosis: In light of these findings, it is proposed that TRAIL not only serves as a biomarker of cardiovascular disease, whereas TRAIL-based therapies may have beneficial pharmacological effects in treating cardiovascular diseases such as atherosclerosis [11].